Regorafenib (off Label)
Regorafenib in ACC
Memorial Sloan Kettering (investigator) · Phase 2 · Completed · Enrollment 38
| Arm | Reported safety |
|---|---|
| Regorafenib | patients with serious adverse events: 14 patients (of 38), results posted |
A count stays a count. This page does not turn a count into a percent.